Most patients find teledermatology appointments suitable alternative to office visits
Researchers at the George Washington University found that the majority of dermatology patients were comfortable with virtual visits as an alternative to in-person appointments
2021-01-25
(Press-News.org) WASHINGTON (Jan. 25, 2021) - The majority of dermatology patients surveyed find telehealth appointments to be a suitable alternative to in-person office visits, according to a survey study from researchers at the George Washington University (GW) Department of Dermatology. The results are published in the Journal of Drugs in Dermatology.
The COVID-19 pandemic changed many aspects of everyday life, including how patients interact with the health care system and seek medical care. Social distancing and stay-at-home orders have led to a move from in-office to virtual visits. While many specialties had to shift to the virtual format because of the pandemic, dermatology had already been experiencing an increase in telehealth visits over the last decade.
"Teledermatology boasts a number of benefits, including increased access to care, cost savings for patients, convenience, and, with the current pandemic, avoids physical contact," said Samuel Yeroushalmi, a third-year medical student at the GW School of Medicine and Health Sciences and first author of the study. However, virtual appointments do come with some drawbacks, including privacy and security concerns, appropriate image acquisition, and appropriate provider training or experience.
To evaluate patient satisfaction with teledermatology appointments, the team distributed an online survey to dermatology patients at the GW Medical Faculty Associates. The survey assessed the patients' reasons for scheduling the telehealth visit, as well as any pandemic-related barriers to care and overall satisfaction with the appointment.
Of the respondents to the survey, 47% reported having a previous appointment cancelled due to COVID-19 and 17.7% were new patients who had not previously had an in-office appointment. Patients reported that they most liked their telehealth experience because they were time efficient, did not require transportation, and effectively maintained social distancing. Reasons patients did not like their virtual appointments include lack of physical touch and feeling they received an inadequate assessment.
When asked if they would recommend telehealth services, only a small minority (6.9%) stated they would not.
"Video calling can certainly present challenges with regard to creating an intimate and collaborative physician-patient relationship compared to in-person encounters, not to mention enhancing certain areas that already have deficiencies," said Adam Friedman, MD, interim chair of the Department of Dermatology and professor of dermatology at the GW School of Medicine and Health Sciences. "Accurate diagnosis of hair, skin, and nails in all skin types has been highlighted as an area in great need of improvement. Telemedicine can easily add an additional layer of complexity, widening the gap and impacting care."
Overall, the team concluded that the majority of patients who had teledermatology appointments found the visits to be an adequate substitute for in-person appointments. The authors suggest that telehealth can and should continue to provide high-quality care for patients of dermatologists during the COVID-19 pandemic in tandem with proper education to ensure meaningful use.
INFORMATION:
The article, titled "Patient Perceptions and Satisfaction with Teledermatology During the COVID-19 Pandemic: A Survey-based Study" is published in the Journal of Drugs in Dermatology and is available at jddonline.com/articles/dermatology/S1545961621P0178X.
ELSE PRESS RELEASES FROM THIS DATE:
2021-01-25
The Special Issue, Volume 10, of Inter Faculty takes up the theme of resonance in the context of the Covid-19 pandemic and its ensuing societal shifts. For, the pandemic this year (2020) reminded us more than ever that we live in 'VUCA' - volatility, uncertainty, complexity and ambiguity. Many things that used to be taken for granted up until a year ago crumbled abruptly and globally. The pandemic struck many aspects or our societies such as public health, economy and social bonds thereby uncovering the vulnerability of the modern society. Universities are no exception to this. Just as one nation by itself cannot tackle these global challenges, neither can these challenges be solved ...
2021-01-25
Using machine learning, researchers at the UC Davis MIND Institute have identified several patterns of maternal autoantibodies highly associated with the diagnosis and severity of autism.
Their study, published Jan. 22 in Molecular Psychiatry, specifically focused on maternal autoantibody-related autism spectrum disorder (MAR ASD), a condition accounting for around 20% of all autism cases.
"The implications from this study are tremendous," said Judy Van de Water, a professor of rheumatology, allergy and clinical immunology at UC Davis and the lead author of the study. "It's the first time that machine learning has been used to identify with 100% accuracy MAR ASD-specific patterns as potential biomarkers of ASD risk."
Autoantibodies are immune proteins ...
2021-01-25
Irvine, Calif., Jan. 25, 2021 -- Scientists at the University of California, Irvine and NASA's Jet Propulsion Laboratory have for the first time quantified how warming coastal waters are impacting individual glaciers in Greenland's fjords. Their work is the subject of a study published recently in Science Advances.
Working under the auspices of the Oceans Melting Greenland mission for the past five years, the researchers used ships and aircraft to survey 226 glaciers in all sectors of one of Earth's largest islands. They found that 74 glaciers situated in deep, steep-walled valleys accounted for nearly half of Greenland's total ice loss between 1992 and 2017.
Such fjord-bound glaciers were discovered to be the ...
2021-01-25
Epilepsy, a neurological disease that causes recurring seizures with a wide array of effects, impacts approximately 50 million people across the world. This condition has been recognized for a long time -- written records of epileptic symptoms date all the way back to 4000 B.C.E. But despite this long history of knowledge and treatment, the exact processes that occur in the brain during a seizure remain elusive.
Scientists have observed distinctive patterns in the electrical activity of neuron groups in healthy brains. Networks of neurons move through states of similar behavior (synchronization) and dissimilar behavior (desynchronization) ...
2021-01-25
A new study demonstrates that antibodies generated by the novel coronavirus react to other strains of coronavirus and vice versa, according to research published today by scientists from Oregon Health & Science University.
However, antibodies generated by the SARS outbreak of 2003 had only limited effectiveness in neutralizing the SARS-CoV-2 virus. Antibodies are blood proteins that are made by the immune system to protect against infection, in this case by a coronavirus.
The study published today in the journal Cell Reports.
"Our finding has some important implications concerning immunity toward different strains of coronavirus infections, ...
2021-01-25
Astrocytes are the most abundant type of cells within the central nervous system (CNS), but they remain poorly characterized. Researchers have long assumed that astrocytes' primary function is to provide nutrients and support for the brain's more closely scrutinized nerve cells; over the years, however, increasing evidence has shown that astrocytes can also actively promote neurodegeneration, inflammation, and neurological diseases. Now, a team led by researchers from Brigham and Women's Hospital, has shown that a specific astrocyte sub-population can do the opposite, instead serving a protective, anti-inflammatory function within the brain based on signals regulated by the bacteria that reside in ...
2021-01-25
-Data demonstrate ADG2 binds to all known variants of SARS-CoV-2 and is not impacted by known circulating resistance mutations-
-Company expects to begin clinical studies for a half-life extended version of ADG2 for the treatment and prevention of COVID-19 in early 2021-
Waltham, MA - January 25, 2021- Adagio Therapeutics, Inc., a biotechnology company developing best-in-class antibodies to broadly neutralize coronaviruses, today published in vitro and in vivo data in Science on its lead antibody candidate, ADG2, which demonstrated similar or higher potency against SARS-CoV-2 compared to other monoclonal antibodies (mAbs) in clinical development and strong binding to all known ...
2021-01-25
Working in preclinical models, researchers report that plitidepsin, a drug with limited clinical approval for the treatment of multiple myeloma, is more potent against SARS-CoV-2 than remdesivir, an antiviral that received FDA emergency use authorization for the treatment of COVID-19 in 2020. The results suggest plitidepsin should be further evaluated as a COVID-19 therapy, the authors say; because it targets a host protein rather than a viral protein, if treatment proves successful in humans, the SARS-CoV-2 virus won't be easily able to gain resistance ...
2021-01-25
A new approach to mapping viral mutations that "escape" leading clinical antibodies has revealed mutations in the SARS-CoV-2 virus that allow it to evade treatments, including a single amino-acid mutation that fully escapes Regeneron's antibody cocktail. These maps, say the authors, demonstrate that prior characterization of escape mutations was incomplete. They will also help to enable immediate interpretation of the effects of the mutations cataloged by viral genomic surveillance, say the authors. Several antibodies are in use or under development as therapies to treat COVID-19. As new SARS-CoV-2 variants emerge, it ...
2021-01-25
Researchers have engineered an antibody that neutralizes SARS-CoV-2 with a potency that "rivals" current lead SARS-CoV-2 clinical neutralizing antibodies, and that also broadly neutralizes a range of clade 1 sarbecoviruses. Their antibody, ADG-2, studied in mice, represents a "promising candidate" for the prevention and treatment of not only COVID-19, they say, but also of future respiratory diseases caused by SARS-related coronaviruses. Although two vaccines and two monoclonal antibody (mAb) therapies have been authorized for emergency use by the FDA, it is unknown whether these vaccines and treatments will provide broad protection against new emerging SARS-CoV-2 strains that originate in humans or animal reservoirs; this is partly ...
LAST 30 PRESS RELEASES:
[Press-News.org] Most patients find teledermatology appointments suitable alternative to office visits
Researchers at the George Washington University found that the majority of dermatology patients were comfortable with virtual visits as an alternative to in-person appointments